Variant report
Variant | esv1011225 |
---|---|
Chromosome Location | chr6:15188151-15198037 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:15194327..15197318-chr6:15210091..15212891,2 | K562 | blood: | |
2 | chr6:15197961..15203179-chr6:15208962..15212023,5 | K562 | blood: | |
3 | chr6:15191202..15192958-chr6:15209892..15211430,2 | K562 | blood: | |
4 | chr6:15197204..15198861-chr6:15320773..15322728,2 | MCF-7 | breast: | |
5 | chr6:15177562..15179581-chr6:15194132..15195996,2 | K562 | blood: | |
6 | chr6:15197961..15202582-chr6:15208962..15214320,4 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DTNBP1-12 | chr6:15197986-15198213 | NONHSAT107863 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs192777561 | chr6:15188155-15188156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs569021717 | chr6:15188198-15188199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530968064 | chr6:15188203-15188204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs35975870 | chr6:15188234-15188235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs3927691 | chr6:15188267-15188268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183661520 | chr6:15188274-15188275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369632037 | chr6:15188275-15188276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113261293 | chr6:15188286-15188287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529697925 | chr6:15188291-15188292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539544865 | chr6:15188320-15188321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553011031 | chr6:15188363-15188364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529253957 | chr6:15193221-15193222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549254675 | chr6:15193248-15193249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553104445 | chr6:15193254-15193255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567276109 | chr6:15193343-15193344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs76486368 | chr6:15193366-15193367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs200337241 | chr6:15193466-15193467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs536218450 | chr6:15193494-15193495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556000810 | chr6:15193495-15193496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569544829 | chr6:15193537-15193538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531946323 | chr6:15193539-15193540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs79209700 | chr6:15193577-15193578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538486593 | chr6:15193606-15193607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs563243428 | chr6:15193630-15193631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558328324 | chr6:15193648-15193649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs34156913 | chr6:15193663-15193664 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs540928341 | chr6:15193685-15193686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34390534 | chr6:15193747-15193748 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs139202943 | chr6:15193753-15193754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185796829 | chr6:15193788-15193789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs543797086 | chr6:15193794-15193795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562867329 | chr6:15193948-15193949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs541142227 | chr6:15193972-15193973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs9383036 | chr6:15193973-15193974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs35107964 | chr6:15193975-15193976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs74959528 | chr6:15193976-15193977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530221166 | chr6:15194023-15194024 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs568705862 | chr6:15194028-15194029 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs527879088 | chr6:15194090-15194091 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs35265495 | chr6:15194107-15194108 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548759721 | chr6:15194139-15194140 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547623327 | chr6:15194165-15194166 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs556542477 | chr6:15194186-15194187 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545315706 | chr6:15194200-15194201 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565491355 | chr6:15194248-15194249 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs62397295 | chr6:15194250-15194251 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs146899032 | chr6:15194310-15194311 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs73724763 | chr6:15194384-15194385 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs556160354 | chr6:15194414-15194415 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs567926318 | chr6:15194484-15194485 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bladder cancer | 21909424 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 16790693 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21785460 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:15184600-15188400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr6:15193200-15194000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr6:15193600-15194000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
4 | chr6:15193600-15195400 | Enhancers | Primary monocytes fromperipheralblood | blood |
5 | chr6:15194000-15194800 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
6 | chr6:15194000-15195400 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
7 | chr6:15194200-15194600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr6:15194200-15195200 | Enhancers | Primary B cells from cord blood | blood |
9 | chr6:15194800-15195000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
10 | chr6:15195000-15195200 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
11 | chr6:15195400-15195600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
12 | chr6:15197400-15197600 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |